Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof
US12285472B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2015 |
| Grant date | Apr 29, 2025 |
| Priority date | — |
| Expiry date | Aug 20, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6006
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a composition, and method of use thereof, comprising self-antigen displaying nanoparticles to target auto-reactive immune components for treating and/or preventing the autoimmune diseases associated therewith. The nanoparticles can also be loaded with cytotoxic drugs for targeted cell killing or with immune-tolerizing compounds to normalize the immune regulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.